Scarica l'app Stockscreener
1.78
0.00%
0.00
Dopo l'orario di chiusura:
1.82
0.04
+2.25%
Precedente Chiudi:
$1.78
Aprire:
$1.78
Volume 24 ore:
966.49K
Relative Volume:
0.70
Capitalizzazione di mercato:
$151.29M
Reddito:
-
Utile/perdita netta:
$-59.69M
Rapporto P/E:
-1.2806
EPS:
-1.39
Flusso di cassa netto:
$-46.54M
1 W Prestazione:
-1.66%
1M Prestazione:
+19.46%
6M Prestazione:
+8.54%
1 anno Prestazione:
+19.46%
Intervallo 1D:
$1.75
$1.81
Intervallo di 1 settimana:
$1.75
$1.905
Portata 52W:
$0.6254
$2.75
Milestone Pharmaceuticals Inc Stock (MIST) Company Profile
Nome
Milestone Pharmaceuticals Inc
Settore
Industria
Telefono
(514) 336-0444
Indirizzo
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, QC
Confronta MIST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MIST
Milestone Pharmaceuticals Inc
|
1.78 | 156.33M | 0 | -59.69M | -46.54M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Milestone Pharmaceuticals Inc Stock (MIST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-05 | Ripresa | H.C. Wainwright | Buy |
| 2024-08-22 | Iniziato | Rodman & Renshaw | Buy |
| 2023-06-20 | Downgrade | Jefferies | Buy → Hold |
| 2022-04-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-03-05 | Iniziato | H.C. Wainwright | Buy |
| 2020-07-29 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-07-24 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-03-25 | Downgrade | Jefferies | Buy → Hold |
| 2020-03-24 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-03-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-06-04 | Iniziato | Oppenheimer | Outperform |
| 2019-06-03 | Iniziato | Cowen | Outperform |
| 2019-06-03 | Iniziato | Jefferies | Buy |
| 2019-06-03 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Milestone Pharmaceuticals Inc Borsa (MIST) Ultime notizie
Tools to assess Milestone Pharmaceuticals Inc.’s risk profile2025 Momentum Check & Daily Price Action Insights - Newser
Visual analytics tools that track Milestone Pharmaceuticals Inc. performanceTrade Performance Summary & Community Verified Watchlist Alerts - Newser
Relative strength of Milestone Pharmaceuticals Inc. in sector analysis2025 Macro Impact & Step-by-Step Trade Execution Guides - Newser
Why Milestone Pharmaceuticals Inc. is moving todayJuly 2025 Summary & Proven Capital Preservation Tips - Newser
Has Milestone Pharmaceuticals Inc. found a price floorJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Historical volatility pattern of Milestone Pharmaceuticals Inc. visualizedEarnings Recap Summary & Daily Profit Maximizing Trade Tips - Newser
Can technical indicators confirm Milestone Pharmaceuticals Inc.’s reversal2025 Earnings Impact & Weekly High Potential Stock Alerts - Newser
Live market analysis of Milestone Pharmaceuticals Inc.Gold Moves & Safe Capital Allocation Plans - Newser
Short interest data insights for Milestone Pharmaceuticals Inc.2025 Technical Overview & Safe Entry Trade Signal Reports - Newser
Is Milestone Pharmaceuticals Inc. still worth holding after the dipJuly 2025 PostEarnings & Short-Term Swing Trade Alerts - Newser
How liquid is Milestone Pharmaceuticals Inc. stock2025 Earnings Impact & Daily Chart Pattern Signals - khodrobank.com
ANI Pharmaceuticals, Inc. (ANIP) Hits Milestone with Cortrophin Gel Prefilled Syringe Launch - Yahoo Finance
Can machine learning forecast Milestone Pharmaceuticals Inc. recoveryJuly 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
What’s the profit margin of Milestone Pharmaceuticals Inc.July 2025 Summary & Long-Term Growth Plans - khodrobank.com
Is Milestone Pharmaceuticals Inc. stock showing strong momentum2025 Winners & Losers & Risk Adjusted Swing Trade Ideas - khodrobank.com
Milestone Pharmaceuticals Inc. stock chart pattern explained2025 Key Lessons & Capital Efficiency Focused Strategies - Newser
Why Milestone Pharmaceuticals Inc. stock attracts strong analyst attentionJuly 2025 Movers & Weekly High Return Opportunities - Newser
Sector ETF Data Correlates with Strength in Milestone Pharmaceuticals Inc.July 2025 Chart Watch & Stock Market Timing Techniques - beatles.ru
How to build a custom watchlist for Milestone Pharmaceuticals Inc.Earnings Summary Report & Community Driven Trade Alerts - Newser
Milestone Pharmaceuticals Inc. Tests 50 Day MA After Sharp Decline getLinesFromResByArray error: size == 0 - kangso.co.kr
Is it time to cut losses on Milestone Pharmaceuticals Inc.Market Growth Review & Detailed Earnings Play Strategies - Newser
Will Milestone Pharmaceuticals Inc. price bounce be sustainable2025 Historical Comparison & Long-Term Capital Growth Strategies - Newser
Price action breakdown for Milestone Pharmaceuticals Inc.Insider Selling & Stock Portfolio Risk Management - Newser
Chart based exit strategy for Milestone Pharmaceuticals Inc.Earnings Overview Report & Growth Focused Entry Point Reports - Newser
Does Milestone Pharmaceuticals Inc. show high probability of rebound2025 Year in Review & Long-Term Capital Growth Ideas - Newser
What to expect from Milestone Pharmaceuticals Inc. in the next 30 daysJuly 2025 Patterns & Real-Time Volume Trigger Notifications - Newser
How to escape a deep drawdown in Milestone Pharmaceuticals Inc.Quarterly Portfolio Report & High Accuracy Buy Signal Tips - Newser
Does Milestone Pharmaceuticals Inc. fit your quant trading modelJuly 2025 Outlook & Short-Term High Return Strategies - Newser
Short interest data insights for Milestone Pharmaceuticals IncTrade Analysis Summary & Comprehensive Market Scan Insights - Newser
How to recover losses in Milestone Pharmaceuticals Inc. stockGold Moves & Risk Managed Investment Signals - Newser
Milestone Pharmaceuticals Inc. Rebound Backed by Sentiment ShiftJuly 2025 Trends & Expert Approved Trade Ideas - sundaytimes.kr
Milestone Pharmaceuticals Inc Azioni (MIST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):